An Update on Lecanemab for Early Stage Alzheimer’s Disease
Автор: UW Memory and Brain Wellness Center/ ADRC
Загружено: 2024-09-27
Просмотров: 4333
On Wed. September 26, 2024, the UW Memory and Brain Wellness Center hosted a webinar titled, An Update on Lecanemab for Early Stage Alzheimer’s Disease
Patients, families, and the wider community are invited to talk about the current amyloid-clearing infusion medications Leqembi (lecanemab) and Kisunla (donanemab) for the treatment of Alzheimer's. Come learn from our panel of experts which include, Dr. Thomas Grabowski, Dr. Michael Rosenbloom and clinical trials coordinator Darla Chapman, ARNP.
• Who is eligible for these treatments?
• What are the risks and benefits?
• What is the process if you're interested in these medications?
• What is the impact of these medications as well as similar ones in the pipeline for the clinic community and research?
• How has it been going for those patients who have been given the Leqembi infusion?
Hosted by the UW Memory and Brain Wellness Center | uwmemoryandbrain.org
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
